Boulder Valley Individual Practice Association, et al.; Agreement Containing Consent Order To Aid Public Comment, 289-291 [E8-31384]
Download as PDF
Federal Register / Vol. 74, No. 2 / Monday, January 5, 2009 / Notices
also will be posted on the Commission’s
Web site at this location.
Karen V. Gregory,
Secretary.
[FR Doc. E8–31277 Filed 1–2–09; 8:45 am]
BILLING CODE 6730–01–P
FEDERAL RESERVE SYSTEM
Change in Bank Control Notices;
Acquisition of Shares of Bank or Bank
Holding Companies
The notificants listed below have
applied under the Change in Bank
Control Act (12 U.S.C. 1817(j)) and
§ 225.41 of the Board’s Regulation Y (12
CFR 225.41) to acquire a bank or bank
holding company. The factors that are
considered in acting on the notices are
set forth in paragraph 7 of the Act (12
U.S.C. 1817(j)(7)).
The notices are available for
immediate inspection at the Federal
Reserve Bank indicated. The notices
also will be available for inspection at
the office of the Board of Governors.
Interested persons may express their
views in writing to the Reserve Bank
indicated for that notice or to the offices
of the Board of Governors. Comments
must be received not later than January
21, 2009.
A. Federal Reserve Bank of St. Louis
(Glenda Wilson, Community Affairs
Officer) P.O. Box 442, St. Louis,
Missouri 63166–2034:
1. Leon Dale Loveall, individually,
and acting in concert with Marlese
Loveall, both of Columbia, Missouri, to
acquire voting shares of Mid America
Banking Corporation, Columbia,
Missouri, and thereby indirectly acquire
voting shares of Mid America Bank &
Trust Company, Dixon, Missouri.
Board of Governors of the Federal Reserve
System, December 30, 2008.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E8–31260 Filed 1–2–09; 8:45 am]
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications also will be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Additional information on all bank
holding companies may be obtained
from the National Information Center
website at www.ffiec.gov/nic/.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
indicated or the offices of the Board of
Governors not later than January 23,
2009.
A. Federal Reserve Bank of San
Francisco (Kenneth Binning, Vice
President, Applications and
Enforcement) 101 Market Street, San
Francisco, California 94105–1579:
1. Franklin Resources, Inc., San
Mateo, California, to acquire up to 8.4
percent of the voting shares of AB&T
Financial Corporation, and thereby
indirectly acquire voting shares of
Alliance Bank & Trust Company, both of
Gastonia, North Carolina.
Board of Governors of the Federal Reserve
System, December 30, 2008.
Jennifer J. Johnson,
Secretary of the Board.
[FR Doc. E8–31261 Filed 1–2–09; 8:45 am]
BILLING CODE 6210–01–S
BILLING CODE 6210–01–S
FEDERAL TRADE COMMISSION
FEDERAL RESERVE SYSTEM
[File No. 051 0252]
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
Boulder Valley Individual Practice
Association, et al.; Agreement
Containing Consent Order To Aid
Public Comment
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR Part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
VerDate Aug<31>2005
14:05 Jan 02, 2009
Jkt 217001
Federal Trade Commission.
ACTION: Proposed Consent Agreement.
AGENCY:
SUMMARY: The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair or
deceptive acts or practices or unfair
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
289
methods of competition. The attached
Analysis to Aid Public Comment
describes both the allegations in the
draft complaint and the terms of the
consent order—embodied in the consent
agreement—that would settle these
allegations.
DATES: Comments must be received on
or before January 22, 2009.
ADDRESSES: Interested parties are
invited to submit written comments.
Comments should refer to ‘‘Boulder
Valley IPA, File No. 051 0252,’’ to
facilitate the organization of comments.
A comment filed in paper form should
include this reference both in the text
and on the envelope, and should be
mailed or delivered to the following
address: Federal Trade Commission/
Office of the Secretary, Room 135-H,
600 Pennsylvania Avenue, N.W.,
Washington, D.C. 20580. Comments
containing confidential material must be
filed in paper form, must be clearly
labeled ‘‘Confidential,’’ and must
comply with Commission Rule 4.9(c).
16 CFR 4.9(c) (2005).1 The FTC is
requesting that any comment filed in
paper form be sent by courier or
overnight service, if possible, because
U.S. postal mail in the Washington area
and at the Commission is subject to
delay due to heightened security
precautions. Comments that do not
contain any nonpublic information may
instead be filed in electronic form by
following the instructions on the webbased form at (https://
secure.commentworks.com/ftcBoulderValleyIPA). To ensure that the
Commission considers an electronic
comment, you must file it on that webbased form.
The FTC Act and other laws the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. All timely and responsive
public comments, whether filed in
paper or electronic form, will be
considered by the Commission, and will
be available to the public on the FTC
website, to the extent practicable, at
www.ftc.gov. As a matter of discretion,
the FTC makes every effort to remove
home contact information for
individuals from the public comments it
receives before placing those comments
on the FTC website. More information,
including routine uses permitted by the
1 The comment must be accompanied by an
explicit request for confidential treatment,
including the factual and legal basis for the request,
and must identify the specific portions of the
comment to be withheld from the public record.
The request will be granted or denied by the
Commission’s General Counsel, consistent with
applicable law and the public interest. See
Commission Rule 4.9(c), 16 CFR 4.9(c).
E:\FR\FM\05JAN1.SGM
05JAN1
290
Federal Register / Vol. 74, No. 2 / Monday, January 5, 2009 / Notices
Privacy Act, may be found in the FTC’s
privacy policy, at (https://www.ftc.gov/
ftc/privacy.shtm).
FOR FURTHER INFORMATION CONTACT:
Constance M. Salemi, FTC Bureau of
Competition, 600 Pennsylvania Avenue,
NW, Washington, D.C. 20580, (202) 3262701.
SUPPLEMENTARY INFORMATION: Pursuant
to section 6(f) of the Federal Trade
Commission Act, 38 Stat. 721, 15 U.S.C.
46(f), and § 2.34 of the Commission
Rules of Practice, 16 CFR 2.34, notice is
hereby given that the above-captioned
consent agreement containing a consent
order to cease and desist, having been
filed with and accepted, subject to final
approval, by the Commission, has been
placed on the public record for a period
of thirty (30) days. The following
Analysis to Aid Public Comment
describes the terms of the consent
agreement, and the allegations in the
complaint. An electronic copy of the
full text of the consent agreement
package can be obtained from the FTC
Home Page (for December 24, 2008), on
the World Wide Web, at (https://
www.ftc.gov/os/2008/12/index.htm). A
paper copy can be obtained from the
FTC Public Reference Room, Room
130-H, 600 Pennsylvania Avenue, NW,
Washington, D.C. 20580, either in
person or by calling (202) 326-2222.
Public comments are invited, and may
be filed with the Commission in either
paper or electronic form. All comments
should be filed as prescribed in the
ADDRESSES section above, and must be
received on or before the date specified
in the DATES section.
Analysis of Agreement Containing
Consent Order To Aid Public Comment
The Federal Trade Commission has
accepted, subject to final approval, an
agreement containing a proposed
consent Order with Boulder Valley
Individual Practice Association
(‘‘BVIPA’’). The agreement settles
charges that BVIPA violated Section 5 of
the Federal Trade Commission Act, 15
U.S.C. § 45, by, among other things,
orchestrating and implementing
agreements among competing physician
members of BVIPA to fix the price at
which BVIPA physicians contract with
health plans.
The proposed consent Order has been
placed on the public record for 30 days
to receive comments from interested
persons. Comments received during this
period will become part of the public
record. After 30 days, the Commission
will review the agreement and the
comments received and decide whether
to withdraw from the agreement or
make the proposed Order final.
VerDate Aug<31>2005
14:05 Jan 02, 2009
Jkt 217001
The purpose of this analysis is to
facilitate public comment on the
proposed Order. The analysis is not
intended to constitute an official
interpretation of the agreement and
proposed Order or to modify their terms
in any way. Further, the proposed
consent Order has been entered into for
settlement purposes only and does not
constitute an admission by the proposed
respondent that it violated the law or
that the facts alleged in the Complaint
(other than jurisdictional facts) are true.
The Complaint
The allegations of the Complaint are
summarized below.
BVIPA is a type of organization
commonly referred to in the health care
industry as an ‘‘independent practice
association’’ because its members
consist of independent physicians in
solo and small group practices. BVIPA
is controlled by its approximately 365
physician members in the Boulder
County, Colorado area.
The Complaint challenges BVIPA’s
conduct starting in 2001, when BVIPA,
on behalf of its members, began to
negotiate the prices and terms in payer
contracts at which its otherwise
competing physician members would
provide services to subscribers of health
plans. BVIPA is governed by a board of
directors consisting of physician
members elected by the membership.
Physicians joining BVIPA sign an
agreement that gives BVIPA the
authority to contract with health plans
on their behalf, and they agree to accept
the payment for their services that
BVIPA negotiates. Members can provide
input to BVIPA on whether a proposed
rate level was acceptable.
Between 2001 and 2006, BVIPA, on
behalf of its members, negotiated and
signed agreements with approximately
17 payers and conducted periodic
renegotiations of its contracts with large
payers to obtain rate increases. BVIPA
threatened payers facing rate increases
with termination of their contracts when
they refused to negotiate or otherwise
respond to BVIPA’s demands. Payers
threatened with termination ultimately
yielded to BVIPA’s price demands.
BVIPA actively discouraged members
from contracting directly with payers.
Some payers attempted to contract with
some of BVIPA’s physician members
with specialties that were important for
the marketing of a provider network,
and found that the providers refused to
contract with payers outside BVIPA.
Consequently, payers had to negotiate
and sign contracts with BVIPA to ensure
that these physicians would participate
in the payers’ health plans.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
In 2004, BVIPA purported to offer
payers three options for contracting
with BVIPA members: a single-signature
contract that ‘‘delivered the entire
BVIPA network,’’ a ‘‘modified
messenger model’’ that ‘‘may or may not
deliver our entire network;’’ and direct
contracting with individual members
outside the IPA. Although BVIPA
claimed to offer payers a choice of
contracting methods, BVIPA did not
develop or use a messenger model, and
it continued to encourage its members
not to contract outside the IPA.
BVIPA’s conduct had the effect of
unreasonably restraining trade and
hindering competition in the provision
of physician services by unreasonably
restraining price and other forms of
competition among physicians;
increasing prices for physician services;
and depriving health plans, employers,
and individual consumers of the
benefits of competition among
physicians. BVIPA members did not
engage in any efficiency-enhancing
integration of their practices sufficient
to justify the its challenged conduct.
Accordingly, the Complaint alleges that
BVIPA violated Section 5 of the FTC
Act.
The Proposed Consent Order
The proposed Order is designed to
remedy the illegal conduct charged in
the Complaint and prevent its
recurrence, while leaving BVIPA free to
engage in legitimate, potentially
procompetitive conduct. It is similar to
recent consent orders that the
Commission has issued to settle charges
that physician groups engaged in
unlawful agreements to raise fees they
receive from health plans.
The proposed Order’s specific
provisions are as follows:
Paragraph II.A prohibits BVIPA from
entering into or facilitating any
agreement between or among any
physicians: (1) to negotiate with payers
on any physician’s behalf; (2) to refuse
to deal, or threaten to refuse to deal,
with payers in furtherance of any
conduct or agreement prohibited by any
other provision of Paragraph II, (3) on
any terms on which a physician is
willing to deal with any payer; or (4) not
to deal individually with any payer, or
not to deal with any payer other than
through BVIPA.
Other parts of Paragraph II reinforce
these general prohibitions. Paragraph
II.B prohibits BVIPA from facilitating
exchanges of information between
physicians concerning any physician’s
willingness to deal with a payer or the
terms or conditions, including price
terms, on which the physician is willing
to deal with a payer. Paragraph II.C bars
E:\FR\FM\05JAN1.SGM
05JAN1
Federal Register / Vol. 74, No. 2 / Monday, January 5, 2009 / Notices
attempts to engage in any action
prohibited by Paragraph II.A, or II.B,
and Paragraph II.D. proscribes BVIPA
from inducing anyone to engage in any
action prohibited by Paragraphs II.A
through II.C.
As in other Commission orders
addressing providers’ collective
bargaining with health-care purchasers,
Paragraph II excludes certain kinds of
agreements from its prohibitions. First,
BVIPA is not precluded from engaging
in conduct that is reasonably necessary
to form or participate in legitimate joint
contracting arrangements among
competing physicians, such as a
‘‘qualified risk-sharing joint
arrangement’’ or a ‘‘qualified clinicallyintegrated joint arrangement.’’ The
arrangement, however, must not restrict
the ability of, or facilitate the refusal of,
physicians who participate in it to
contract with payers outside of the
arrangement.
As defined in the proposed Order, a
‘‘qualified risk-sharing joint
arrangement’’ possesses two
characteristics. First, all physician
participants must share substantial
financial risks through the arrangement,
such that the arrangement creates
incentives for the physician participants
jointly to control costs and improve
quality by managing the provision of
services. Second, any agreement
concerning reimbursement or other
terms or conditions of dealing must be
reasonably necessary to obtain
significant efficiencies through the joint
arrangement.
A ‘‘qualified clinically-integrated joint
arrangement,’’on the other hand, need
not involve any sharing of financial risk.
Instead, as defined in the proposed
Order, physician participants must
participate in active and ongoing
programs to evaluate and modify their
clinical practice patterns in Order to
control costs and ensure the quality of
services provided, and the arrangement
must create a high degree of
interdependence and cooperation
among physicians. As with qualified
risk-sharing arrangements, any
agreement concerning price or other
terms of dealing must be reasonably
necessary to achieve the efficiency goals
of the joint arrangement.
Paragraph III, for three years, requires
BVIPA to notify the Commission before
it enters into any arrangements to act as
a messenger or an agent on behalf of any
physicians, with payers regarding
contracts. Paragraph IV sets out the
information necessary to make the
notification complete.
Paragraph V, for three years, requires
BVIPA to notify the Commission before
participating in contracting with health
VerDate Aug<31>2005
17:13 Jan 02, 2009
Jkt 217001
plans on behalf of either a qualified risksharing or a qualified clinicallyintegrated joint arrangement. Paragraph
VI sets out the information necessary to
satisfy the notification requirement.
Paragraph VII imposes other
notification obligations on BVIPA and
requires the termination of certain
contracts that were entered into
illegally. Paragraphs VII.A requires
BVIPA to distribute the Complaint and
the Order to (1) physicians who have
participated in BVIPA since 2001; (2) to
various past and current personnel of
BVIPA; and (3) to payers with whom
BVIPA has dealt since 2001. Paragraph
VII.B requires BVIPA, at any payer’s
request and without penalty, to
terminate its existing contracts with the
payer for the provision of physician
services. Paragraph VII.B. allows certain
contracts currently in effect to be
extended at the written request of the
payer no longer than one year from the
date that the Order becomes final.
Paragraph VII.C requires BVIPA to
distribute payer requests for contract
termination to physicians who
participate in the contract. Paragraph
VII.D requires BVIPA, for three years, to
provide new members, personnel, and
payers not previously receiving a copy,
a copy of the Order and the Complaint.
Paragraph VII.D also requires BVIPA to
publish annually a copy of the Order
and the Complaint in its newsletter.
Paragraphs VIII, IX, and X impose
various obligations on BVIPA to report
or provide access to information to the
Commission to facilitate the monitoring
of compliance with the Order. Finally,
Paragraph XI provides that the Order
will expire in 20 years.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E8–31384 Filed 1–2–09: 8:45 am]
BILLING CODE 6750–01–S
FEDERAL TRADE COMMISSION
[File No. 061 0258]
Independent Practice Associates
Medical Group, Inc.; Agreement
Containing Consent Order To Aid
Public Comment
Federal Trade Commission.
Proposed Consent Agreement.
AGENCY:
ACTION:
The consent agreement in this
matter settles alleged violations of
federal law prohibiting unfair or
deceptive acts or practices or unfair
methods of competition. The attached
Analysis to Aid Public Comment
describes both the allegations in the
SUMMARY:
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
291
draft complaint and the terms of the
consent order—embodied in the consent
agreement—that would settle these
allegations.
DATES: Comments must be received on
or before January 22, 2009.
ADDRESSES: Interested parties are
invited to submit written comments.
Comments should refer to ‘‘AllCareIPA,
File No. 061 0258,’’ to facilitate the
organization of comments. A comment
filed in paper form should include this
reference both in the text and on the
envelope, and should be mailed or
delivered to the following address:
Federal Trade Commission/Office of the
Secretary, Room 135-H, 600
Pennsylvania Avenue, N.W.,
Washington, D.C. 20580. Comments
containing confidential material must be
filed in paper form, must be clearly
labeled ‘‘Confidential,’’ and must
comply with Commission Rule 4.9(c).
16 CFR 4.9(c) (2005).1 The FTC is
requesting that any comment filed in
paper form be sent by courier or
overnight service, if possible, because
U.S. postal mail in the Washington area
and at the Commission is subject to
delay due to heightened security
precautions. Comments that do not
contain any nonpublic information may
instead be filed in electronic form by
following the instructions on the webbased form at (https://
secure.commentworks.com/ftcAllCareIPA). To ensure that the
Commission considers an electronic
comment, you must file it on that webbased form.
The FTC Act and other laws the
Commission administers permit the
collection of public comments to
consider and use in this proceeding as
appropriate. All timely and responsive
public comments, whether filed in
paper or electronic form, will be
considered by the Commission, and will
be available to the public on the FTC
website, to the extent practicable, at
www.ftc.gov. As a matter of discretion,
the FTC makes every effort to remove
home contact information for
individuals from the public comments it
receives before placing those comments
on the FTC website. More information,
including routine uses permitted by the
Privacy Act, may be found in the FTC’s
privacy policy, at (https://www.ftc.gov/
ftc/privacy.shtm).
1 The comment must be accompanied by an
explicit request for confidential treatment,
including the factual and legal basis for the request,
and must identify the specific portions of the
comment to be withheld from the public record.
The request will be granted or denied by the
Commission’s General Counsel, consistent with
applicable law and the public interest. See
Commission Rule 4.9(c), 16 CFR 4.9(c).
E:\FR\FM\05JAN1.SGM
05JAN1
Agencies
[Federal Register Volume 74, Number 2 (Monday, January 5, 2009)]
[Notices]
[Pages 289-291]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-31384]
=======================================================================
-----------------------------------------------------------------------
FEDERAL TRADE COMMISSION
[File No. 051 0252]
Boulder Valley Individual Practice Association, et al.; Agreement
Containing Consent Order To Aid Public Comment
AGENCY: Federal Trade Commission.
ACTION: Proposed Consent Agreement.
-----------------------------------------------------------------------
SUMMARY: The consent agreement in this matter settles alleged
violations of federal law prohibiting unfair or deceptive acts or
practices or unfair methods of competition. The attached Analysis to
Aid Public Comment describes both the allegations in the draft
complaint and the terms of the consent order--embodied in the consent
agreement--that would settle these allegations.
DATES: Comments must be received on or before January 22, 2009.
ADDRESSES: Interested parties are invited to submit written comments.
Comments should refer to ``Boulder Valley IPA, File No. 051 0252,'' to
facilitate the organization of comments. A comment filed in paper form
should include this reference both in the text and on the envelope, and
should be mailed or delivered to the following address: Federal Trade
Commission/Office of the Secretary, Room 135-H, 600 Pennsylvania
Avenue, N.W., Washington, D.C. 20580. Comments containing confidential
material must be filed in paper form, must be clearly labeled
``Confidential,'' and must comply with Commission Rule 4.9(c). 16 CFR
4.9(c) (2005).\1\ The FTC is requesting that any comment filed in paper
form be sent by courier or overnight service, if possible, because U.S.
postal mail in the Washington area and at the Commission is subject to
delay due to heightened security precautions. Comments that do not
contain any nonpublic information may instead be filed in electronic
form by following the instructions on the web-based form at (https://
secure.commentworks.com/ftc-BoulderValleyIPA). To ensure that the
Commission considers an electronic comment, you must file it on that
web-based form.
---------------------------------------------------------------------------
\1\ The comment must be accompanied by an explicit request for
confidential treatment, including the factual and legal basis for
the request, and must identify the specific portions of the comment
to be withheld from the public record. The request will be granted
or denied by the Commission's General Counsel, consistent with
applicable law and the public interest. See Commission Rule 4.9(c),
16 CFR 4.9(c).
---------------------------------------------------------------------------
The FTC Act and other laws the Commission administers permit the
collection of public comments to consider and use in this proceeding as
appropriate. All timely and responsive public comments, whether filed
in paper or electronic form, will be considered by the Commission, and
will be available to the public on the FTC website, to the extent
practicable, at www.ftc.gov. As a matter of discretion, the FTC makes
every effort to remove home contact information for individuals from
the public comments it receives before placing those comments on the
FTC website. More information, including routine uses permitted by the
[[Page 290]]
Privacy Act, may be found in the FTC's privacy policy, at (https://
---------------------------------------------------------------------------
www.ftc.gov/ftc/privacy.shtm).
FOR FURTHER INFORMATION CONTACT: Constance M. Salemi, FTC Bureau of
Competition, 600 Pennsylvania Avenue, NW, Washington, D.C. 20580, (202)
326-2701.
SUPPLEMENTARY INFORMATION: Pursuant to section 6(f) of the Federal
Trade Commission Act, 38 Stat. 721, 15 U.S.C. 46(f), and Sec. 2.34 of
the Commission Rules of Practice, 16 CFR 2.34, notice is hereby given
that the above-captioned consent agreement containing a consent order
to cease and desist, having been filed with and accepted, subject to
final approval, by the Commission, has been placed on the public record
for a period of thirty (30) days. The following Analysis to Aid Public
Comment describes the terms of the consent agreement, and the
allegations in the complaint. An electronic copy of the full text of
the consent agreement package can be obtained from the FTC Home Page
(for December 24, 2008), on the World Wide Web, at (https://www.ftc.gov/
os/2008/12/index.htm). A paper copy can be obtained from the FTC Public
Reference Room, Room 130-H, 600 Pennsylvania Avenue, NW, Washington,
D.C. 20580, either in person or by calling (202) 326-2222.
Public comments are invited, and may be filed with the Commission
in either paper or electronic form. All comments should be filed as
prescribed in the ADDRESSES section above, and must be received on or
before the date specified in the DATES section.
Analysis of Agreement Containing Consent Order To Aid Public Comment
The Federal Trade Commission has accepted, subject to final
approval, an agreement containing a proposed consent Order with Boulder
Valley Individual Practice Association (``BVIPA''). The agreement
settles charges that BVIPA violated Section 5 of the Federal Trade
Commission Act, 15 U.S.C. Sec. 45, by, among other things,
orchestrating and implementing agreements among competing physician
members of BVIPA to fix the price at which BVIPA physicians contract
with health plans.
The proposed consent Order has been placed on the public record for
30 days to receive comments from interested persons. Comments received
during this period will become part of the public record. After 30
days, the Commission will review the agreement and the comments
received and decide whether to withdraw from the agreement or make the
proposed Order final.
The purpose of this analysis is to facilitate public comment on the
proposed Order. The analysis is not intended to constitute an official
interpretation of the agreement and proposed Order or to modify their
terms in any way. Further, the proposed consent Order has been entered
into for settlement purposes only and does not constitute an admission
by the proposed respondent that it violated the law or that the facts
alleged in the Complaint (other than jurisdictional facts) are true.
The Complaint
The allegations of the Complaint are summarized below.
BVIPA is a type of organization commonly referred to in the health
care industry as an ``independent practice association'' because its
members consist of independent physicians in solo and small group
practices. BVIPA is controlled by its approximately 365 physician
members in the Boulder County, Colorado area.
The Complaint challenges BVIPA's conduct starting in 2001, when
BVIPA, on behalf of its members, began to negotiate the prices and
terms in payer contracts at which its otherwise competing physician
members would provide services to subscribers of health plans. BVIPA is
governed by a board of directors consisting of physician members
elected by the membership. Physicians joining BVIPA sign an agreement
that gives BVIPA the authority to contract with health plans on their
behalf, and they agree to accept the payment for their services that
BVIPA negotiates. Members can provide input to BVIPA on whether a
proposed rate level was acceptable.
Between 2001 and 2006, BVIPA, on behalf of its members, negotiated
and signed agreements with approximately 17 payers and conducted
periodic renegotiations of its contracts with large payers to obtain
rate increases. BVIPA threatened payers facing rate increases with
termination of their contracts when they refused to negotiate or
otherwise respond to BVIPA's demands. Payers threatened with
termination ultimately yielded to BVIPA's price demands.
BVIPA actively discouraged members from contracting directly with
payers. Some payers attempted to contract with some of BVIPA's
physician members with specialties that were important for the
marketing of a provider network, and found that the providers refused
to contract with payers outside BVIPA. Consequently, payers had to
negotiate and sign contracts with BVIPA to ensure that these physicians
would participate in the payers' health plans.
In 2004, BVIPA purported to offer payers three options for
contracting with BVIPA members: a single-signature contract that
``delivered the entire BVIPA network,'' a ``modified messenger model''
that ``may or may not deliver our entire network;'' and direct
contracting with individual members outside the IPA. Although BVIPA
claimed to offer payers a choice of contracting methods, BVIPA did not
develop or use a messenger model, and it continued to encourage its
members not to contract outside the IPA.
BVIPA's conduct had the effect of unreasonably restraining trade
and hindering competition in the provision of physician services by
unreasonably restraining price and other forms of competition among
physicians; increasing prices for physician services; and depriving
health plans, employers, and individual consumers of the benefits of
competition among physicians. BVIPA members did not engage in any
efficiency-enhancing integration of their practices sufficient to
justify the its challenged conduct. Accordingly, the Complaint alleges
that BVIPA violated Section 5 of the FTC Act.
The Proposed Consent Order
The proposed Order is designed to remedy the illegal conduct
charged in the Complaint and prevent its recurrence, while leaving
BVIPA free to engage in legitimate, potentially procompetitive conduct.
It is similar to recent consent orders that the Commission has issued
to settle charges that physician groups engaged in unlawful agreements
to raise fees they receive from health plans.
The proposed Order's specific provisions are as follows:
Paragraph II.A prohibits BVIPA from entering into or facilitating
any agreement between or among any physicians: (1) to negotiate with
payers on any physician's behalf; (2) to refuse to deal, or threaten to
refuse to deal, with payers in furtherance of any conduct or agreement
prohibited by any other provision of Paragraph II, (3) on any terms on
which a physician is willing to deal with any payer; or (4) not to deal
individually with any payer, or not to deal with any payer other than
through BVIPA.
Other parts of Paragraph II reinforce these general prohibitions.
Paragraph II.B prohibits BVIPA from facilitating exchanges of
information between physicians concerning any physician's willingness
to deal with a payer or the terms or conditions, including price terms,
on which the physician is willing to deal with a payer. Paragraph II.C
bars
[[Page 291]]
attempts to engage in any action prohibited by Paragraph II.A, or II.B,
and Paragraph II.D. proscribes BVIPA from inducing anyone to engage in
any action prohibited by Paragraphs II.A through II.C.
As in other Commission orders addressing providers' collective
bargaining with health-care purchasers, Paragraph II excludes certain
kinds of agreements from its prohibitions. First, BVIPA is not
precluded from engaging in conduct that is reasonably necessary to form
or participate in legitimate joint contracting arrangements among
competing physicians, such as a ``qualified risk-sharing joint
arrangement'' or a ``qualified clinically-integrated joint
arrangement.'' The arrangement, however, must not restrict the ability
of, or facilitate the refusal of, physicians who participate in it to
contract with payers outside of the arrangement.
As defined in the proposed Order, a ``qualified risk-sharing joint
arrangement'' possesses two characteristics. First, all physician
participants must share substantial financial risks through the
arrangement, such that the arrangement creates incentives for the
physician participants jointly to control costs and improve quality by
managing the provision of services. Second, any agreement concerning
reimbursement or other terms or conditions of dealing must be
reasonably necessary to obtain significant efficiencies through the
joint arrangement.
A ``qualified clinically-integrated joint arrangement,''on the
other hand, need not involve any sharing of financial risk. Instead, as
defined in the proposed Order, physician participants must participate
in active and ongoing programs to evaluate and modify their clinical
practice patterns in Order to control costs and ensure the quality of
services provided, and the arrangement must create a high degree of
interdependence and cooperation among physicians. As with qualified
risk-sharing arrangements, any agreement concerning price or other
terms of dealing must be reasonably necessary to achieve the efficiency
goals of the joint arrangement.
Paragraph III, for three years, requires BVIPA to notify the
Commission before it enters into any arrangements to act as a messenger
or an agent on behalf of any physicians, with payers regarding
contracts. Paragraph IV sets out the information necessary to make the
notification complete.
Paragraph V, for three years, requires BVIPA to notify the
Commission before participating in contracting with health plans on
behalf of either a qualified risk-sharing or a qualified clinically-
integrated joint arrangement. Paragraph VI sets out the information
necessary to satisfy the notification requirement.
Paragraph VII imposes other notification obligations on BVIPA and
requires the termination of certain contracts that were entered into
illegally. Paragraphs VII.A requires BVIPA to distribute the Complaint
and the Order to (1) physicians who have participated in BVIPA since
2001; (2) to various past and current personnel of BVIPA; and (3) to
payers with whom BVIPA has dealt since 2001. Paragraph VII.B requires
BVIPA, at any payer's request and without penalty, to terminate its
existing contracts with the payer for the provision of physician
services. Paragraph VII.B. allows certain contracts currently in effect
to be extended at the written request of the payer no longer than one
year from the date that the Order becomes final. Paragraph VII.C
requires BVIPA to distribute payer requests for contract termination to
physicians who participate in the contract. Paragraph VII.D requires
BVIPA, for three years, to provide new members, personnel, and payers
not previously receiving a copy, a copy of the Order and the Complaint.
Paragraph VII.D also requires BVIPA to publish annually a copy of the
Order and the Complaint in its newsletter.
Paragraphs VIII, IX, and X impose various obligations on BVIPA to
report or provide access to information to the Commission to facilitate
the monitoring of compliance with the Order. Finally, Paragraph XI
provides that the Order will expire in 20 years.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. E8-31384 Filed 1-2-09: 8:45 am]
BILLING CODE 6750-01-S